Inovio Pharmaceuticals Stock (NASDAQ: INO) stock price, news, charts, stock research, profile.
Open | $10.42 |
Close | $11.18 |
Volume / Avg. | 415.16K / 371.24K |
Day Range | 10.36 - 11.25 |
52 Wk Range | 3.89 - 14.75 |
Market Cap | $286.57M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 7.91% |
Days to Cover | 2.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.
Other companies in Inovio Pharmaceuticals’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP), Monte Rosa Therapeutics (NASDAQ:GLUE) and Design Therapeutics (NASDAQ:DSGN).
There is no analysis for Inovio Pharmaceuticals.
Inovio Pharmaceuticals has a consensus price target of $14.83.
The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $11.06 last updated July 23, 2024 at 7:30 PM EDT.
There are no upcoming dividends for Inovio Pharmaceuticals.
Inovio Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Inovio Pharmaceuticals.
Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.